Small Molecule Antiviral Agents Against Flaviviruses

Award Information
Agency:
Department of Defense
Branch
Army
Amount:
$100,000.00
Award Year:
2012
Program:
SBIR
Phase:
Phase I
Contract:
W81XWH-12-C-0006
Agency Tracking Number:
A112-106-0271
Solicitation Year:
2011
Solicitation Topic Code:
A11-106
Solicitation Number:
2011.2
Small Business Information
BIOO Scientific
3913 Todd Lane, Suite 312, Austin, TX, -
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
Y
Duns:
611930244
Principal Investigator:
Joseph Krebs
Director
(512) 707-8993
jkrebs@biooscientific.com
Business Contact:
Lance Ford
Manager
(512) 707-8993
lford@biooscientific.com
Research Institution:
Stub




Abstract
Flaviviruses are a major health threat worldwide. This family of RNA viruses causes a variety of deadly diseases such as Dengue Fever, Yellow Fever, West Nile virus, and Tick-borne Encephalitis. There are currently no effective means to control these viruses. New drugs to counteract these viruses are desperately needed. Flaviviruses block the body's immune response by inhibiting nuclease enzymes which degrade viral RNA. Our goal is to identify small molecules to disrupt these flavivirus nuclease inhibitors to increase the cell's antiviral response. We will develop a high-throughput fluorescence polarization assay to identify novel small molecule disruptors of the viral inhibitor from compound libraries. We will also identify novel RNA-disrupting compounds using computer modeling techniques. The novel drugs identified will be synthesized and tested using flavivirus-infected cells in tissue culture to confirm biological activity.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government